Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-10

Clinical Trial Update: Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease

View source ↗

Summary

The clinical trial evaluating the cellular proteome from leukocytes in glaucoma patients and in patients with Parkinson's disease has been withdrawn. This is an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Parkinson's Disease, Glaucoma | Status: WITHDRAWN